Internal Medicine, Gastroenterology · Hartford, KY
NPI
1548262918
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
112 E McMurtry Ave
Hartford, KY, 42347
Phone (270) 298-7225
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
658 services
Medicare patients, 2024
233
Average age 72
Drug cost, 2024
$1.2M
2,659 prescriptions
Company payments, 2025
$297
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles W Riccio was code 99214 (office e&m - established), 183 times for 113 patients. In total Charles W Riccio billed 658 services in 30 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 183 | 113 | $65.96 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 96 | 63 | $11.31 | $1,086 |
| 43239 Upper GI Endoscopy | Facility | 61 | 57 | $62.39 | $3,806 |
| 99214 Office E&M - Established | Office | 45 | 32 | $88.51 | $3,983 |
| 99213 Office E&M - Established | Facility | 44 | 41 | $39.23 | $1,726 |
| 99204 Office E&M - New | Facility | 38 | 38 | $84.89 | $3,226 |
| 45378 Lower GI Endoscopy - Other | Facility | 32 | 30 | $113.66 | $3,637 |
| 99222 Hospital E&M - Initial | Facility | 25 | 25 | $93.34 | $2,333 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 15 | $11.58 | $220 |
| 45380 Lower GI Endoscopy - Other | Facility | 16 | 16 | $129.50 | $2,072 |
| 45384 Colonoscopy - Lesion Removal | Facility | 16 | 16 | $162.18 | $2,595 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 13 | 13 | $168.85 | $2,195 |
| 45385 Colonoscopy - Lesion Removal | Facility | 13 | 13 | $190.83 | $2,481 |
By year: 2022 $55K for 670 services; 2023 $52K for 635 services; 2024 $46K for 658 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles W Riccio prescribed most often to Medicare patients was Omeprazole, with 464 prescriptions and refills. In total Charles W Riccio wrote 2,659 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 464 | 717 | 96 | $3,816 |
| Pantoprazole Sodium Generic | 336 | 602 | 77 | $3,789 |
| Linzess Linaclotide | 202 | 248 | 39 | $131K |
| Colestipol Hcl Generic | 165 | 211 | 37 | $7,750 |
| Alosetron Hcl Generic | 80 | 82 | 15 | $91K |
| Dexlansoprazole Dr Dexlansoprazole | 65 | 86 | 11 | $10K |
| Esomeprazole Magnesium Generic | 63 | 104 | 14 | $1,122 |
| Metoclopramide Hcl Generic | 54 | 68 | 17 | $324 |
| Dicyclomine Hcl Generic | 54 | 60 | 19 | $529 |
| Sucralfate Generic | 48 | 65 | 22 | $5,287 |
| Lubiprostone Generic | 47 | 49 | Under 11 | $3,129 |
| Movantik Naloxegol Oxalate | 47 | 63 | Under 11 | $26K |
| Trulance Plecanatide | 41 | 57 | Under 11 | $31K |
| Lactulose Generic | 39 | 45 | 14 | $720 |
| Megestrol Acetate Generic | 36 | 42 | Under 11 | $1,550 |
Brand drugs: - claims; generic drugs: 2,039 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles W Riccio $297 ($297 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $144.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.